Dcf Advisers, LLC has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $242 Million distributed in 97 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Micron Technology Inc with a value of $18.3M, Alphabet Inc. with a value of $11.6M, Argenx Se with a value of $10.8M, Regeneron Pharmaceuticals, Inc. with a value of $8.15M, and Intra Cellular Therapies, Inc. with a value of $7.35M.

Examining the 13F form we can see an increase of $56.9M in the current position value, from $185M to 242M.

Dcf Advisers, LLC is based out at Greenwich, CT

Below you can find more details about Dcf Advisers, LLC portfolio as well as his latest detailed transactions.

Portfolio value $242 Million
ETFs: $71.9 Million
Healthcare: $64.9 Million
Technology: $44 Million
Communication Services: $19 Million
Consumer Cyclical: $15 Million
Financial Services: $14.3 Million
Energy: $4.96 Million
Consumer Defensive: $3.1 Million
Other: $4.76 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 97
  • Current Value $242 Million
  • Prior Value $185 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 4 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Dcf Advisers, LLC Portfolio

Follow Dcf Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.